ManagedCareCGM

Continuous Glucose Monitoring

Education for Managed Care, Pharmacy, and Payer Professionals

Effect of Continuous Glucose Monitoring on Glycemic Control, Acute Admissions, and Quality of Life: A Real-World Study

Source: The Journal of Clinical Endocrinology & Metabolism

Key Takeaway: Nationwide reimbursement of real-time CGM improved HbA1c, fear of hypoglycemia, and QOL as well as economic indicators including work absenteeism and hospital admissions for acute diabetes complications.

The Value of rtCGM: Reduction in Hospitalizations and Work Absenteeism
  Pre-Reimbursement for rtCGM Post-Reimbursement for rtCGM P Value
  (n = 496) (n = 379)  
Patients with      
    Hospitalizations due to hypoglycemia and/or ketoacidosis 77 (16%) 14 (4%) <0.0005
    Hospitalizations due to hypoglycemia 59 (11%) 12 (3%) <0.0005
    Hospitalizations due to ketoacidosis 23 (5%) 4 (1%) 0.092
    Work absenteesim* 123 (25%) 36 (9%) <0.0005
Days (per 100 patient years) of       
    Hospitalizations due to hypoglycemia and/or ketoacidosis 53.5 17.8 <0.0005
    Hospitalizations due to hypoglycemia 38.5 12.5 0.001
    Hospitalizations due to ketoacidosis 14.9 5.3 0.220
    Work absenteeism 494.5 233.8 0.001

Data are n (%).

*Work absenteeism of at least half a day. Patient-reported hospital admissions were validated by clinicians.

Reference: Charleer S, et al. Clin Endocrinol Metab. 2018;103(3):1224–1232

The Value of rtCGM: Improved Population Glycemic Control


Reference: Charleer S, Mathieu C, Nobels F, et al. J Clin Endocrinol Metab. 2018;103(3):1224-1232.